Clinical Trials Logo

Endophthalmitis clinical trials

View clinical trials related to Endophthalmitis.

Filter by:

NCT ID: NCT03363295 Completed - Cataract Clinical Trials

Evaluation of Macular Changes After Intracameral Moxifloxacin for Prevention of Endophthalmitis

Start date: July 1, 2017
Phase: Phase 4
Study type: Interventional

The objective of this study is to evaluate the macular and choroidal thickness of patients submitted to intracameral moxifloxacin during the phacoemulsification surgery for endophthalmitis prophylaxis. The investigators propose a randomized clinical trial double-blind. The patients will be divided into two groups: one will receive intracameral moxifloxacin injection during phacoemulsification surgery and the other won't. Both Spectral Domain - Optical Coherence Tomography (SD-OCT) and Enhanced Depth Imaging - Optical Coherence Tomography (EDI-OCT) will be performed for each patient pre-operatively and on the 30th and 60th postoperative days. After collecting, the data will be compared to evaluate if there was any difference in the macular thickness and choroidal thickness between the two groups.

NCT ID: NCT02818062 Completed - Endophthalmitis Clinical Trials

Severe Intraocular Infection

Start date: January 2008
Phase: N/A
Study type: Observational

The host-immune reaction to infection is essential for the comprehension of the disease and the development of new therapies. The aim of the study is to describe intraocular cytokines network in aqueous humor using multiplex immunoassay, during severe intraocular infection.

NCT ID: NCT02595359 Completed - Endophthalmitis Clinical Trials

Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis

Start date: January 2013
Phase: Phase 2
Study type: Interventional

The aim of this study was to evaluate the efficacy and safety of the prophylactic effect of intracameral moxifloxacin for prevention of postcataract endophthalmitis.

NCT ID: NCT02136589 Completed - Clinical trials for Intraocular Pressure

Effect of NSAID on Travoprost-induced Conjunctival Hyperemia and IOP Reduction in Normal Eyes

ENTICHIR
Start date: September 2008
Phase: Phase 4
Study type: Interventional

PG-analogues induce hyperemia as one of side effects in addition to IOP reduction. IOP reduction is caused by direct FP receptor stimulation, but the cause of hyperemia is not clarified. Because FP receptor stimulation induce intrinsic production of PGs, hyperemia or IOP reduction may be due to secondary induced PGs. Thus, pretreatment with NSAID may affect the PG-analogue induced hyperemia or IOP reduction.

NCT ID: NCT01768078 Completed - Clinical trials for Post-operative Endophthalmitis

Interest of Intravitreal Corticotherapy as the First-line Treatment for Post-operative Endophthalmitis

Endophtalmitis
Start date: September 2008
Phase: Phase 3
Study type: Interventional

One useful effect of early intravitreal corticotherapy is to diminish inflammatory complications after endophthalmitis, which may cause, at least in part, serious complications (retinal detachment, macular edema) which are, more than the infection, causes of the complications seen after acute endophthalmitis.

NCT ID: NCT01323868 Completed - Endophthalmitis Clinical Trials

Endogenous Endophthalmitis in the Inpatient Setting

Start date: July 2010
Phase: N/A
Study type: Observational

The purpose of this study is to determine the rate of endogenous endophthalmitis in patients admitted to Stanford Hospital with a systemic infection and positive blood cultures, as this may improve the clinical care of this population of patients.

NCT ID: NCT00730938 Completed - Cataract Clinical Trials

The Effect of Intracameral Cefuroxime on Post-op Fibrin in Pediatric Cataract Surgery

Start date: February 2008
Phase: N/A
Study type: Interventional

The study investigates whether placing an antibiotic inside the eye at the end of cataract surgery in children will reduce the amount of fibrin formation (fibrin formation can block the pupil and reduce vision). We hypothesize that the fibrin is caused by a low-level infection and could be prevented by the antibiotic.

NCT ID: NCT00461656 Completed - Surgery Clinical Trials

Povidone-iodine Antisepsis for Strabismus Surgery

PASS
Start date: September 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the efficacy of 5 % vs. 1.25 % povidone-iodine (PI) as preoperative antiseptic prior to strabismus surgery in children as a prophylaxis of endophthalmitis. Given the low rate of endophthalmitis the conjunctival bacterial flora rate is used as surrogate marker to determine the effectiveness of topical PI in reducing or eliminating bacteria from the ocular surface at the time of the surgery. Secondary objective is a reduction of the incidence of postoperative endophthalmitis after strabismus surgery in young children.

NCT ID: NCT00406913 Completed - Cataract Surgery Clinical Trials

Prophylaxis Prior to Cataract Surgery Conjunctival Flora and Optimal Ocular Sterilization Technique Prior to Cataract Surgery

Start date: October 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the conjunctival flora prior to cataract or vitrectomy surgery comparing mupirocin ointment applied to the conjunctiva along with standard ocular sterilization vs. standard ocular sterilization alone.

NCT ID: NCT00398658 Completed - Endophthalmitis Clinical Trials

Prophylaxis of Acute Post-Traumatic Bacterial Endophthalmitis

Start date: March 2002
Phase: Phase 4
Study type: Interventional

Purpose: To evaluate the efficacy of combined intraocular injection of gentamycin and clindamycin in prevention of acute posttraumatic bacterial endophthalmitis (APBE) following penetrating eye injuries. Design: Multicenter, randomized, double masked, controlled trial. Participants: Three hundred forty six eyes of 346 patients with penetrating eye injury. Method: Following primary repair, eyes were randomized to receive a 0.1 ml intracameral or intravitreal injection of 40µg gentamycin and 45µg clindamycin (cases), versus intracameral or intravitreal injection of 0.1ml balanced saline solution (controls). All patients received standard prophylactic antibiotic therapy (systemic, subconjunctival and topical). Main outcome measures: Occurrence of endophthalmitis within two weeks after primary repair.